Skip to main content
SpringerLink
Log in

Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ashford MW, Liu W, Lin SJ, Abraszewski P, Caruthers SD, Connolly AM, Yu X, Wickline SA (2005) Occult cardiac contractile dysfunction in dystrophindeficient children revealed by cardiac magnetic resonance strain imaging. Circulation 112:2462–2467

    Article  PubMed  Google Scholar 

  2. Bastianutto C, Bestard JA, Lahnakoski K, Broere D, De Visser M, Zaccolo M, Pozzan T, Ferlini A, Muntoni F, Patarnello T, Klamut HJ (2001) Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with Xlinked dilated cardiomyopathy. Hum Mol Genet 10:2627–2635

    Article  PubMed  CAS  Google Scholar 

  3. Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J (2005) The multidisciplinary management of Duchenne muscular dystrophy. Current Paediatrics 15:292–300

    Article  Google Scholar 

  4. Groh WJ, Zipes DP (2005) Neurological disorders and cardiovascular diseases. In: Braunwald E (ed) Heart diseases, 7th edition. Elsevier Saunders, Philadelphia, pp 2145–2160

  5. Hoogerwaard EM, van der Wouw PA, Wilde AAM, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M (1999) Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 9:347–351

    Article  PubMed  CAS  Google Scholar 

  6. Hoshino S, Ohkoshi N, Watanabe M, Shoji S (2000) Immunohistochemical staining of dystrophin on formalinfixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy. Neuromuscul Disord 10:425–429

    Article  PubMed  CAS  Google Scholar 

  7. Kinali M, Robinson R, Sagi L, Nihoyannopoulos P, Manzur A, Muntoni F (2007) The role of ACE inhibitor therapy in presymptomatic cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord 17:816

    Article  Google Scholar 

  8. Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S (2005) Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol 26:66–72

    Article  PubMed  CAS  Google Scholar 

  9. Mavrogeni S, Tzelepis GE, Athanasopoulos G, Maounis T, Douskou M, Papavasiliou A, Cokkinos DV (2005) Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy. Chest 127:143–148

    Article  PubMed  Google Scholar 

  10. Mc Nelly EM (2007) New approaches in the therapy of cardiomyopathy in muscular dystrophy. Ann Rev Med 58:75–88

    Article  Google Scholar 

  11. Schade van Westrum SM, Dekker L, Endert E, de Haan RJ, Wilde AAM, de Visser M, van der Kooi AJ (2006) NTproBNP is not associated with dilated cardiomyopathy in Becker and Duchenne muscular dystrophies. Neuromuscul Disord 16:698–669

    Google Scholar 

  12. Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    A. Barison MD & A. Balbarini MD

  2. CNR, Gabriele Monasterio Foundation and Institute of Clinical Physiology, National Research Council, Via Moruzzi 1, 56124, Pisa, Italy

    G. D. Aquaro MD, C. Passino MD, M. Lombardi MD & M. Emdin MD, PhD

  3. Scuola Superiore Sant’Anna, Piazza Martiri della Libertà 33, 56127, Pisa, Italy

    C. Passino MD

  4. Dept. of Neuroscience, Section of Neurology, University of Pisa, Via Roma 67, 56126, Pisa, Italy

    M. Falorni MD, L. Pasquali MD, PhD & G. Siciliano MD, PhD

Authors
  1. A. Barison MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. D. Aquaro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Passino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Falorni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Balbarini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Lombardi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Pasquali MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Emdin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Siciliano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Emdin MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barison, A., Aquaro, G.D., Passino, C. et al. Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier. J Neurol 256, 283–284 (2009). https://doi.org/10.1007/s00415-009-0055-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-0055-7

Keywords

Search

Navigation